Genpro Research is a next-generation service and technology partner for the pharmaceutical, biotechnology, and medical device industries. Our tools use Artificial Intelligence, Machine Learning, and Natural Language Processing algorithms to automate a variety of processes during drug development and post-launch activities. We offer advanced solutions in Biostatistics & Programming, Medical Writing, and Regulatory Submissions. Genpro has a diverse talent pool of professionals with several years of industry experience, as well as a young and energetic set of professionals from some of the leading institutions. MAIA is a cutting-edge end-to-end framework that improves efficiency and alleviates the pain points associated with literature reviews. This platform quickly generates high-quality literature review summaries, disease context summaries, TA landscaping, and Systematic Literature Reviews (SLRs) for Epidemiology, Medical Affairs, and Medical Information teams. It can reduce the cognitive workload of writers and analysts by 50-70%. MAIA was created and tested in collaboration with one of the world's top five pharmaceutical companies. To learn more about MAIA, visit: genproresearch.com/MaiA. Genpro brings together the world's best practices in Clinical Data Management, Biostatistics, Programming, Medical Writing, and Strategic Consulting. Since Genpro's inception, we have pursued a rapid and ambitious expansion strategy, establishing offices in Boston USA, and India development centers in Thiruvananthapuram, Kochi, Baroda, and Bangalore. Each of these offices performs a specific function that allows us to better serve our customers. Genpro provides an excellent work-life balance by implementing globally flexible work practices. For over 15 years, the Genpro team has been involved in NDA/BLA/PMA submissions, interacting with FDA/EMEA & PMDA, and actively collaborating with academic, industry, and FDA working groups.
